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Abstract
Introduction/hypothesis Disturbances in skeletal muscle fatty
acid (FA) handling may contribute to the development and
progression of whole-body insulin resistance (IR). In this
study, we compared fasting and postprandial skeletal muscle
FA handling in individuals with varying degrees of IR.
Methods Seventy-four overweight/obese participants (62
men) were divided into two groups based on the HOMA-IR
median (3.35). Fasting and postprandial skeletal muscle FA
handling were determined by combining the forearm muscle
balance technique with stable isotopes. [2H2]palmitate was
infused i.v. to label VLDL-triacylglycerol (VLDL-TAG) and
NEFA in the circulation, whereas [U-13C]palmitate was incor-
porated in a high-saturated FA mixed-meal labelling chylomi-
cron-TAG. Skeletal muscle biopsies were taken to assess in-
tramuscular lipid content, fractional synthetic rate (FSR) and
the transcriptional regulation of FA metabolism.
Results Postprandial forearm muscle VLDL-TAG extraction
was elevated in the high-IR vs the mild-IR group (AUC0-4h:
0.57±0.32 vs −0.43±0.38 nmol [100ml tissue]−1min−1, respec-
tively, p=0.045). Although no differences in skeletal muscle
TAG, diacylglycerol, NEFA content and FSR were present be-
tween groups, the high-IR group showed increased saturation of
the intramuscular NEFApool (p=0.039). This was accompanied
by lower muscle GPAT1 (also known as GPAM) expression
(p=0.050).
Conclusions/interpretation Participants with high-IR demon-
strated increased postprandial skeletal muscle VLDL-TAG
extraction and higher saturation of the intramuscular NEFA
pool vs individuals with mild-IR. These data support the in-
volvement of disturbances in skeletal muscle FA handling in
the progression of whole-body IR.
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FSR Fractional synthetic rate
IFG Impaired fasting glucose
IGT Impaired glucose tolerance
IR Insulin resistance
LPL Lipoprotein lipase
MUFA Monounsaturated fatty acid
PL Phospholipid
PUFA Polyunsaturated fatty acid
RaNEFA Rate of appearance of NEFA




Systemic lipid overflow, which is driven by adipose tissue
dysfunction and impaired skeletal muscle lipid handling, is
associated with insulin resistance (IR) [1]. Increased circulat-
ing triacylglycerol (TAG) and NEFA concentrations are often
found in IR because of impaired adipose tissue lipid handling
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[2–4]. This results in an increased lipid supply to other non-
adipose tissues, such as liver and skeletal muscle. Due to an
impaired capacity to oxidise fatty acids (FAs) [5, 6], these
lipids may accumulate and interfere with insulin signalling
in the liver and skeletal muscle [7, 8]. Over the last decade,
it has become clear that the amount of lipids per se does not
determine IR. Rather, a complex interplay between FA supply,
FA type, muscle lipid turnover, subcellular localisation and
composition of specific bioactive lipid metabolites seems to
determine skeletal muscle IR [1, 8, 9].
The contribution of dietary fat (chylomicron-TAG) and en-
dogenous fat (NEFA and VLDL-TAG) to skeletal muscle FA
handling is not well understood. Elevated plasma NEFA con-
centrations may result from both expanded fat mass [2] and
reduced peripheral clearance [5, 10]. Despite a reduced lipol-
ysis per unit fat mass because of hyperinsulinaemia [11, 12],
the total amount of NEFA released from adipose tissue in the
postprandial state seems to be elevated in the obese insulin
resistant state [13]. Furthermore, in situations with plasma
insulin concentrations comparable to insulin levels achieved
during a hyperinsulinaemic–euglycaemic clamp, the spillover
from FAs derived from lipoprotein lipase (LPL)-mediated
TAG hydrolysis in adipose tissue has been shown to be less
suppressed in obese patients with type 2 diabetes than in non-
obese healthy controls [14]. This increase in adipose tissue
NEFA output might lead to increased hepatic VLDL-TAG
production and elevated plasma TAG concentrations [15,
16]. Bickerton et al [17] demonstrated that dietary FAs were
preferentially taken up in adipose tissue and skeletal muscle in
the postprandial state in healthy lean humans, even though
VLDL particles were abundantly present after the meal [11].
Up to now, most studies investigating combined VLDL-
and chylomicron-TAG metabolism have been performed in
healthy, lean humans [17, 18]. Bickerton et al [11] have shown
elevated postprandial plasma VLDL- and chylomicron-TAG
concentrations in overweight men with IR [11]. Moreover, we
have recently demonstrated that an increased postprandial
VLDL-TAG extraction was associated with IR in men with
the metabolic syndrome [19]. However, studies involving the
combined assessment of human skeletal muscle VLDL- and
chylomicron-TAG metabolism, and intramuscular lipid spe-
cies are limited. In addition, previous studies have used a
relatively small sample size due to methodological difficulties
as well as the high costs associated with these measurements.
Therefore, extensive human in vivo data on skeletal muscle
FA handling in IR are currently lacking. The aim of this study
was to investigate fasting and postprandial skeletal muscle FA
handling in a large study cohort of overweight or obese par-
ticipants with a wide range of IR. A dual stable isotope tracer
technique using labelled palmitate in combination with mea-
surements of differences in arteriovenous concentrations
across forearm muscle and forearm blood flow was used in
this study, as previously validated [17]. This enabled us to
differentiate between the metabolic fate of dietary and endog-
enous FA. In addition, skeletal muscle biopsies were taken to
investigate skeletal muscle lipid metabolites, their fractional
synthetic rates (FSRs) and the transcriptional regulation of FA
metabolism.
Methods
Study participants Seventy-four participants (62 men and 12
women) with the metabolic syndrome or impaired glucose
metabolism were obtained from the Maastricht biobank.
These participants (described elsewhere in more detail
[19–21]) underwent a high-saturated FA (SFA) mixed-meal
test. Participants were divided into two groups based on the
median of HOMA-IR (3.35); participants below the median of
HOMA-IR formed the ‘mild-IR’ group (n=37) and partici-
pants above the median formed the ‘high-IR’ group (n=37).
The local Medical Ethical Committee of Maastricht
University Medical Center+ approved the study protocols.
All participants gave their written informed consent before
participation.
High-fat mixed-meal test Participants were studied after an
overnight fast and were asked to refrain from strenuous exer-
cise and drinking alcohol for 24 h before the study day. In
addition, they were asked to avoid food products naturally
enriched with 13C for 7 days before the study day. Forearm
muscle metabolism was studied using arteriovenous concentra-
tion differences combinedwithmeasurements of forearm blood
flow. Three catheters were inserted before the start of the ex-
periment. One catheter was placed retrogradely into a superfi-
cial dorsal vein of a hand heated in a hot-box (60°C) to obtain
an arterialised blood sample. In the same arm another catheter
was placed in an antecubital vein for the infusion of the
[2H2]palmitate tracer. A third catheter was placed retrogradely
in a deep antecubital vein of the contralateral forearm to sample
venous blood draining the forearm muscle. After taking an
arterialised and deep-venous background sample at 90 min be-
fore meal ingestion, a continuous i.v. infusion of the stable
isotope tracer, [2H2]palmitate (97% enrichment; Cambridge
Isotope Laboratories, Andover, MA, USA) complexed to albu-
min was started (0.035 μmol [kg body weight]−1 min−1).
Baseline blood sampling was started after 1 h of tracer infusion
to allow for isotopic equilibration to occur. Blood samples were
taken simultaneously from the dorsal hand vein and the deep
muscle vein at three time points during fasting. Samples were
also taken at six time points postprandially after consumption
of a high-SFA mixed-meal (at ‘0 min’) containing 200 mg
[U-13C]palmitate (98% enrichment; Cambridge Isotope
Laboratories). The liquid meal provided 2.6 MJ energy,
consisting of 61 energy % (E%) fat (35.5 E%, SFA; 18.8 E%,
monounsaturated FA [MUFA]; 1.7 E% polyunsaturated FA
Diabetologia (2016) 59:2686–2696 2687
[PUFA]), 33 E% carbohydrates and 6.3 E% protein. Analysis
of forearm blood flow before blood sampling and details of
other biochemical analyses have been described previously
[19].
Skeletal muscle biopsies Skeletal muscle biopsies were obtain-
ed from the vastus lateralis muscle after local anaesthesia of the
skin and fascia using the Bergström method with suction [22].
Muscle biopsies were taken during fasting and at the end of the
postprandial period (240 min). Muscle biopsies were lyophilised
and dissected free of extramyocellular lipid, blood and connec-
tive tissue under a microscope. Details of lipid extraction and
quantification have been described previously [19]. Skeletal
muscle expression of genes related to transcription factors, oxi-
dative metabolism, lipid synthesis and lipolysis were analysed.
Gene expression was normalised relative to the geometric mean
of the internal reference genes (β-actin, β-2-microglobulin and/
or ribosomal protein L13a). Details of accession numbers, RNA
primer sequences andRT-PCR analysis of these genes have been
described previously [19, 20]. Since limited muscle biopsy sam-
ples were available, not all genes have been measured in all
individuals.
Calculations Net fluxes of metabolites (labelled and
unlabelled) across the forearm were calculated by multiplying
the arteriovenous concentration difference by forearm plasma
flow. Plasma flow was measured using plethysmography and
calculated by multiplying forearm blood flow with
([1-haematocrit (%vol.)]/100). A positive flux indicates net
uptake across forearm muscle, whereas a negative flux indi-
cates net release. Labelled NEFA and TAG concentrations
were calculated as the product of tracer:tracee ratio (TTR) of
[2H2]palmitate and [U-
13C]palmitate and the concentration of
palmitate in NEFA and TAG, as reported previously [19].
The degree of saturation of skeletal muscle TAG, diacyl-
glycerol (DAG), phospholipid (PL) and NEFA (%) was cal-
culated by dividing the sum of unsaturated FAs by the total
amount of FAs in a fraction multiplied by 100. The FSR of
skeletal muscle NEFA, TAG, DAG and PL was calculated
using skeletal muscle NEFA as the precursor pool for lipid
synthesis. The increase in TTR of [U-13C] from fasting to
4 h postprandial measures was divided by the enrichment of
skeletal muscle NEFA and expressed as per cent per hour
(%/h). Postprandial areas under the curve (AUC0-4h) of me-
tabolites were calculated using the trapezium rule and in this
study data are presented as AUC0-4h/min.
Statistics In this study all data are expressed as mean±SEM.
Participant characteristics and differences in skeletal muscle
lipid handling during fasting and postprandial conditions of
the mild-IR and high-IR group were compared using indepen-
dent samples t tests. A linear regression was performed with
HOMA-IR and BMI and sex as co-variates. Variables were
loge-transformed if the assumption of normality was not met.
The data were analysed using SPSS for Mac version 22.0
(SPSS, Chicago, IL, USA) and statistical significance was
set at p<0.05.
Results
Study population Participant characteristics are summarised
in Table 1. Age, waist:hip ratio and blood pressure were com-
parable between groups, while BMI was significantly higher
in the high-IR group (p=0.002). By design, mean HOMA-IR
was different between the two groups (mild-IR vs high-IR:
2.5±0.1 vs 4.7±0.3, respectively, p<0.001).
Arterialised metabolites, forearm muscle metabolism and
forearm blood flow Fasting arterialised plasma glucose
(Fig. 1a) and insulin (Fig. 1b) concentrations were significant-
ly higher in the high-IR group than in the mild-IR group
(p=0.002 and p<0.001, respectively) and remained higher
throughout the postprandial period (p=0.035 and p<0.001,
respectively). Net glucose uptake across forearm muscle was
similar in the high-IR and mild-IR groups under fasting con-
ditions, but was significantly lower in the high-IR group than
in the mild-IR group after meal ingestion (AUC0-4h
0.59±0.04 vs 0.76±0.07 μmol [100 ml tissue]−1 min−1, re-
spectively, p=0.034), indicating a lower postprandial insulin
sensitivity in the high-IR group (see Table 2 and Fig. 1c).
Arterialised fasting plasma glycerol concentrations
(p = 0.006) and lactate concentrations were significantly
higher (p=0.006) in the high-IR group than in the mild-IR
group (Table 2). Forearm blood flow and glycerol release were
similar between the two IR groups, both during fasting and
postprandial conditions. Moreover, fasting (p=0.002) and
postprandial (p=0.048) lactate release was positively associ-
ated with IR (Table 2).
Whole-body and forearm muscle NEFA metabolism
Fasting arterialised NEFA concentrations were similar in the
high-IR and mild-IR groups (Fig. 2a). After the high-SFA
meal ingestion, arterialised NEFA concentrations decreased
to the same extent in both groups and returned to near-
baseline values at the end of the postprandial period, with no
significant differences observed between the groups.
[2H2]palmitate was infused i.v. and was mixed with the plas-
ma NEFA pool. The TTR reached steady state during fasting
measurements (Fig. 2c, d). Consistent with these findings, the
rate of appearance of NEFA (RaNEFA) decreased after the meal
(Fig. 2b), which is an indication of suppression of whole-body
lipolysis. A reduction in postprandial suppression of the
RaNEFA was observed in the high-IR group compared with
the mild-IR group, although the difference did not reach sta-
tistical significance (p = 0.079, Fig. 2b). There were no
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differences in arterialised concentrations of [2H2]palmitate
and [U-13C]palmitate in NEFA between groups (data not
shown).
The TTR of [2H2]palmitate in NEFA was higher in
arterialised vs deep-venous plasma at all time points in both
groups. This reflects dilution of the [2H2] tracer in the plasma
NEFA pool across forearm muscle. The TTR of
[U-13C]palmitate in NEFA (resulting from spillover of FA
derived from chylomicron-TAG hydrolysis) was not different
in arterialised vs deep-venous plasma at all time points in both
groups (Fig. 2c, d).
Fasting and postprandial net extraction of plasma NEFA
across forearm muscle did not differ between groups.
Furthermore, there was consistent uptake of [2H2]palmitate
across forearm muscle during the study period and this was
similar in both groups (Table 2).
Whole-body and forearm muscle TAG metabolism
Comparable arterialised TAG concentrations between the
high-IR and mild-IR groups were observed during fasting
and postprandial conditions (Fig. 3a). The [2H2]palmitate trac-
er was measurable in plasma TAG from the first baseline
sample onwards, reflecting incorporation of the i.v. infused
tracer into VLDL-TAG (Fig. 3b). The [U-13C]palmitate tracer,
which was given with the meal, appeared in plasma TAG from
60 min after meal ingestion, representing chylomicron-TAG
in the circulation (Fig. 3b). During the postprandial period
both labelled TAG fractions increased without significant dif-
ferences between groups.
Fasting net extraction of [2H2]palmitate TAG across fore-
arm muscle was higher in the high-IR group than in the mild-
IR group, although the difference did not reach statistical sig-
nificance (p = 0.069). Postprandial net extraction of
[2H2]palmitate TAG was significantly elevated in the high-
IR group vs the mild-IR group (p=0.045) (Fig. 3c). In line
with this, we found a significant linear association between
postprandial net extraction of [2H2]palmitate TAG and
HOMA-IR, even after adjustment for BMI and sex
(standardised β=0.294; p=0.037; Table 2). The net extrac-
tion of [U-13C]palmitate TAG across forearm muscle could be
detected from 60 min onwards and did not differ significantly
between groups (Table 2, Fig. 3d).










Male (n)/Female (n) 33/4 29/8 62/12
Age (years) 58.0 ± 1.4 59.0 ± 1.1 58.5 ± 0.9 36–70 0.582
Body weight (kg) 89.8 ± 1.9 95.1 ± 2.1 92.5 ± 1.4 64.0–115.0 0.064
BMI (kg/m2) 29.2 ± 0.5 31.7 ± 0.6 30.5 ± 0.4 22.7–39.5 0.002
Waist:hip ratio 1.02 ± 0.01 1.03± 0.01 1.02± 0.01 0.89–1.17 0.494
Systolic blood pressure (mmHg) 135 ± 2 136 ± 2 135 ± 2 105–174 0.636
Diastolic blood pressure (mmHg) 84 ± 2 85± 1 85 ± 1 68–110 0.944
Fasting plasma glucose (mmol/l) 5.4 ± 0.1 5.7 ± 0.1 5.5 ± 0.1 4.6–6.7 0.002
Fasting plasma insulin (pmol/l) 72.3 ± 2.4 130.2 ± 6.6 101.2 ± 4.9 50–263.3 <0.001
Fasting plasma NEFA (μmol/l) 561 ± 22 598 ± 26 580 ± 17 296–1002 0.287
Fasting plasma TAG (μmol/l) 1320± 103 1246± 85 1283± 66 415–3232 0.582
HOMA-IR 2.5 ± 0.1 4.7 ± 0.3 3.6 ± 0.2 1.68–11.3 <0.001
Values are presented as mean ± SEM
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Fig. 1 Arterialised plasma glucose (a) and insulin (b) concentrations and
glucose flux (c) during fasting (0 min) and after consumption of a high-
SFA meal. Black circles, mild-IR group; white circles, high-IR group.
Student’s t test for unpaired samples showed significant effect of group
on fasting and postprandial plasma glucose (p = 0.002 and AUC0-4h:
p = 0.035, respectively), fasting and postprandial plasma insulin
(p< 0.001 and AUC0-4h: p < 0.001, respectively) and postprandial glu-
cose flux (AUC0-4h: p= 0.034). Values are presented as mean± SEM
Diabetologia (2016) 59:2686–2696 2689
Intramuscular lipid metabolism Skeletal muscle TAG,
DAG and NEFA content were comparable between high-IR
andmild-IR groups (Table 3). The PL content was lower in the
high-IR group than in the mild-IR group, although the
difference did not reach statistical significance (60.5±3.2 vs
70.2 ± 3.6 μmol/[g dry weight], respectively, p = 0.055).
However, there was no significant linear association between
PL and measures of IR (Table 3). Intramuscular lipid
Table 2 Fasting and
postprandial lipid
metabolism
Variable Mild-IR High-IR p valuea Total group SE β p valueb
Forearm blood flow (ml [100 ml tissue]−1 min−1)
Fasting 2.5 ± 0.2 2.5 ± 0.2 0.896 0.054 0.682
Postprandial 2.6 ± 0.2 2.8 ± 0.2 0.476 0.118 0.369
Glycerol (μmol/l)
Fasting 84.6 ± 3.9 118.5 ± 11.1 0.006 0.200 0.090
Postprandial 64.9 ± 3.6 92.9 ± 10.6 0.016 0.278 0.025
Lactate (μmol/l)
Fasting 0.62± 0.04 0.79± 0.05 0.006 0.438 <0.001
Postprandial 0.98 ± 0.05 1.10± 0.05 0.081 0.224 0.087
Net flux across forearm muscle
Glucose (μmol [100 ml tissue]−1 min−1)
Fasting 0.23± 0.05 0.17± 0.03 0.274 −0.083 0.524
Postprandial 0.76 ± 0.07 0.59± 0.04 0.034 −0.147 0.226
Glycerol (nmol [100 ml tissue]−1 min−1)
Fasting −28.3 ± 5.5 −27.0 ± 7.7 0.883 0.224 0.092
Postprandial −20.4 ± 4.5 −25.2 ± 6.5 0.541 0.081 0.543
Lactate (nmol [100 ml tissue]−1 min−1)
Fasting −0.18± 0.02 −0.12 ± 0.03 0.123 0.384 0.002
Postprandial 0.01 ± 0.02 0.04± 0.03 0.472 0.249 0.048
NEFA (nmol [100 ml tissue]−1 min−1)
Fasting −6.9 ± 20.4 26.6 ± 24.6 0.300 0.165 0.210
Postprandial −0.8 ± 9.5 8.7 ± 13.4 0.565 0.112 0.405
[2H2]palmitate NEFA (nmol [100 ml tissue]
−1 min−1)
Fasting 1.69± 0.12 1.58± 0.14 0.539 0.017 0.902
Postprandial 1.50 ± 0.09 1.53± 0.14 0.846 0.171 0.208
TAG (nmol [100 ml tissue]−1 min−1)
Fasting 10.2 ± 13.2 45.5 ± 12.1 0.052 0.094 0.466
Postprandial 53.9 ± 17.2 51.9 ± 28.4 0.954 −0.105 0.422
[2H2]palmitate TAG (nmol [100 ml tissue]
−1 min−1)
Fasting −0.24± 0.16 0.56± 0.41 0.069 0.241 0.076
Postprandial −0.43± 0.38 0.57± 0.32 0.045 0.294 0.037
[U-13C]palmitate TAG (nmol [100 ml tissue]−1 min−1)
Fastingc
Postprandial 0.86 ± 0.16 0.66± 0.16 0.353 −0.046 0.736
Values are presented as mean± SEM
Postprandial values are calculated from AUC0-4h
A positive flux indicates net uptake across forearm muscle, whereas a negative flux indicates net release
a p value for difference between mild-IR and high-IR group, Student’s t test for unpaired samples
b p value for multiple linear regression
c [U-13C]palmitate was given with the high-SFA meal, hence fasting data are not available.
[2 H2]palmitate TAG fasting, n = 34; [
2 H2]palmitate NEFA postprandial and [U-
13 C]palmitate TAG postprandial, n= 33;
[2H2]palmitate TAG postprandial (mild-IR), n = 29; [
2H2]palmitate TAG postprandial (high-IR), n= 32
SE β, standardised β coefficient for HOMA-IR, adjusted for sex and BMI
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composition was different between groups, with a significant-
ly higher degree of saturation in the muscle NEFA pool in
participants with high-IR compared with those with mild-IR
(51.8±2.8% vs 43.9±2.5%, respectively, p=0.039), but there
was no significant linear association with IR (Table 3). This
difference was mainly explained by higher percentages of
myristic acid (C14:0; 3.5 ± 0.7% vs 2.1 ± 0.4%, p=0.078),
pentadecyclic acid (C15:0; 4.5 ± 1.5% vs 1.2 ± 0.3%,
p = 0.038) and tricosylic acid (C23:0; 3.0 ± 1.1% vs 0.8
± 0.4%, p=0.064) in the high-IR group vs mild-IR group
(Fig. 4a). Furthermore, the percentage of PUFA in the NEFA
pool was lower in the high-IR group than in the mild-IR group
(13.0±1.1% vs 17.0±1.4%, p=0.034; Table 3). In addition,
lipid composition in the intramuscular DAG pool differed
between high-IR and mild-IR groups (Table 3): in the high-
IR group, the percentage PUFA was significantly lower
(p=0.022). Linear regression showed a non-significant nega-
tive association between the percentage of PUFA in the DAG
pool and HOMA-IR. Furthermore, a higher percentage of
MUFA was observed in the DAG pool of the high-IR group
compared with the mild-IR group (p = 0.052; Table 3).
Although the total saturation of the lipid content in the DAG
pool did not differ between groups (Table 3), the percentage of
palmitate (C16:0) in the DAG pool of the high-IR group was
significantly higher compared with that in the mild-IR group
(22.1±0.7% vs 24.6±0.8%, respectively, p=0.024; Fig. 4b).
The FSR of skeletal muscle TAG, DAG and PL was com-
parable between groups (Table 3), indicating that a similar
proportion of palmitate from the intramuscular NEFA pool
was directed towards storage after the high-SFA meal.
Fasting skeletal muscle mRNA expression of genes
encoding proteins involved in oxidative metabolism, lipid
synthesis and lipolysis is shown in Table 4. Skeletal muscle
gene expression of GPAT1 (also known as GPAM), a gene
involved in lipid synthesis, was significantly lower
(p=0.050) in the high-IR group than in the mild-IR group,
even when adjusted for sex and BMI using linear regression
analysis (standardised β=−0.666; p=0.002). Furthermore,
the expression level of NDUFB5, encoding a subunit of com-
plex I in the electron transport chain, tended to be lower in the
high-IR vs the mild-IR group (p=0.062), whilst the expres-
sion of the intracellular lipase gene ATGL (also known as
PNPLA2) tended to be higher in the high-IR group (p=0.052).
Discussion
The present study demonstrated that postprandial forearm
muscle VLDL-TAG extraction was elevated in individuals
with high-IR compared with mild-IR. This elevation in
VLDL-TAG extraction was accompanied by increased satu-
ration of the intramuscular NEFA pool. Both effects were
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Fig. 3 Postprandial whole-body and forearm muscle TAG metabolism.
Arterialised plasma TAG concentrations (a), [2H2]- and [U-
13C]palmitate
concentrations in the plasma TAG fraction (b), and the net flux of
[2H2]palmitate TAG (c) and [U-
13C]palmitate TAG (d) across forearm
muscle during fasting (0 min) and after consumption of a high-SFAmeal.
A positive flux indicates net uptake across forearm muscle, whereas a
negative flux indicates net release. Black symbols, mild-IR group; white
symbols, high-IR group; in (b) circles, [2H2]palmitate TAG and triangles,
[U-13C]palmitate TAG. Student’s t test for unpaired samples showed a
significant effect of group on postprandial net flux of [2H2]palmitate TAG







































































0 60 120 180 240 0 60 120 180 240
























Fig. 2 Postprandial whole-body NEFA metabolism. Arterialised plasma
NEFA concentrations (a), RaNEFA (b), and the TTR of [
2H2]palmitate (c)
and [U-13C]palmitate (d) in the plasma NEFA fraction during fasting
(0 min) and after consumption of a high-SFA meal. Black symbols,
mild-IR group; white symbols, high-IR group; in (c) and (d) circles,
arterialised plasma concentrations and triangles, forearm venous plasma
concentrations. Values are presented as mean± SEM
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important role for disturbances in skeletal muscle FA handling
in the progression of whole-body IR.
Disturbances in skeletal muscle FA handling have been im-
plicated in the aetiology of IR and type 2 diabetes [1, 23]. Our
group has recently demonstrated that higher postprandial plasma
TAG concentrations and increased net TAG extraction across
forearm muscle were accompanied by decreased postprandial
insulin sensitivity in participants with impaired glucose metabo-
lism compared with normal glucose tolerance [24]. Furthermore,
we showed a higher postprandial VLDL-TAG extraction by
skeletal muscle in men with IR compared with controls with
the metabolic syndrome, matched for age and BMI, despite a
similar TAG supply [19]. More recently, we demonstrated that
increased muscle VLDL-TAG extraction and reduced lipid turn-
over of SFA, rather than DAG content, accompany the more
pronounced IR observed in humans with impaired glucose tol-
erance (IGT) comparedwith impaired fasting glucose (IFG) [20].
The present data extend our previous observations regard-
ing FA handling by showing that postprandial forearm muscle
VLDL-TAG extraction was elevated in participants with high-
IR when compared with those with mild-IR. We included
participants who encompassed the entire spectrum of insulin
sensitivity, from insulin-sensitive to very-insulin-resistant
states (HOMA-IR, 1.7–11.3) and with a wide range of adipos-
ity (BMI, 22.7–39.5 kg/m2). This allowed us to differentiate
between the effect of obesity and IR per se, and our present
findings confirm those of previous studies that have suggested
the existence of a relationship between impaired skeletal mus-
cle FA handling and IR [1, 8, 25]. Moreover, our data imply
that IR is primarily responsible for increased postprandial
forearm muscle VLDL-TAG extraction, since we observed a
significant linear association between VLDL-TAG extraction
and IR. A potential mechanism for increased skeletal muscle
VLDL-TAG extraction in participants with high-IR may in-
volve differential apolipoprotein composition of the VLDL
particles [16]. For example, higher plasma apoCII:apoCIII
ratios have been shown in diabetic individuals, compared with
a control group [26]. This variation in lipid composition might
Table 3 Skeletal muscle lipid
content and composition during
fasting and the FSR of the muscle





p valuea Total group SE β p valueb
NEFA
Total (μmol/[g dry weight]) 5.9 ± 0.8 4.9 ± 0.8 0.360 −0.058 0.642
% SFA 43.9 ± 2.5 51.8 ± 2.8 0.039 0.219 0.112
% MUFA 39.1 ± 1.9 35.2 ± 2.3 0.183 −0.183 0.162
% PUFA 17.0 ± 1.4 13.0 ± 1.1 0.034 −0.162 0.266
FSR (%/h) 0.38 ± 0.05 0.36 ± 0.07 0.747 −0.069 0.619
DAG
Total (μmol/[g dry weight]) 10.8 ± 2.8 6.2 ± 0.7 0.151 −0.195 0.160
% SFA 37.8 ± 1.9 36.6 ± 0.8 0.594 −0.093 0.535
% MUFA 44.2 ± 1.6 47.6 ± 0.6 0.052 0.255 0.086
% PUFA 18.0 ± 0.8 15.7 ± 0.5 0.022 −0.271 0.059
FSR (%/h) 0.33 ± 0.05 0.29 ± 0.05 0.538 −0.058 0.692
TAG
Total (μmol/[g dry weight]) 182.6 ± 24.3 232.1 ± 42.5 0.301 0.126 0.365
% SFA 36.7 ± 0.9 35.8 ± 0.9 0.477 −0.157 0.273
% MUFA 47.9 ± 1.0 50.1 ± 0.7 0.076 0.046 0.749
% PUFA 15.3 ± 0.8 14.1 ± 1.0 0.325 0.112 0.444
FSR (%/h) 0.28 ± 0.05 0.21 ± 0.04 0.325 −0.186 0.209
PL
Total (μmol/[g dry weight]) 70.2 ± 3.6 60.5 ± 3.2 0.055 −0.155 0.260
% SFA 41.3 ± 0.8 40.4 ± 0.6 0.364 −0.046 0.754
% MUFA 11.3 ± 0.3 11.4 ± 0.5 0.903 0.017 0.909
% PUFA 47.4 ± 1.0 48.2 ± 0.7 0.496 0.030 0.838
FSR (%/h) 0.10 ± 0.01 0.09 ± 0.01 0.486 −0.006 0.966
Values are presented as mean ± SEM
a p value for difference between mild-IR and high-IR group, Student’s t test for unpaired samples
b p value for multiple linear regression
SE β, standardised β coefficient for HOMA-IR, adjusted for sex and BMI
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lead to higher a susceptibility for lipid degradation by in vivo
skeletal muscle LPL [27]. Of note, we did not perform mea-
surements in the late postprandial phase. It has been shown that
dietary FAs appear in VLDL-TAG from 2–3 h after meal in-
gestion, making it difficult to separate chylomicron- and
VLDL-TAG in the late postprandial phase using the current
dual isotope approach [17, 28, 29]. Therefore, we cannot ex-
clude the possibility that the increased TAG extraction observed
in high-IR participants may also extend to chylomicron-TAG.
In this context, an impaired inhibitory effect of insulin on skel-
etal muscle LPL action in the high-IR group [30], or impaired
FA uptake via membrane-associated carrier proteins like CD36
[31] might possibly explain the observed differences.
In addition to an increased skeletal muscle lipid uptake, we
observed differences in the intramyocellular FA partitioning
between groups. Reduced re-esterification of NEFA into TAG
may expose muscle to excess NEFA concentrations and
bioactive lipid metabolites that may interfere with insulin
signalling [23]. In line with this, a reduced incorporation of
NEFA into TAG in primary myotubes from obese individuals
with type 2 diabetes has previously been shown [32], indicat-
ing that the ability to incorporate FAs into TAG is an intrinsic
feature of human muscle cells that is reduced in individuals
with type 2 diabetes. Moreover, in vitro work has shown that
muscle cells incubated with palmitate incorporated more FA
towards the DAG pool, while the unsaturated FAs were
diverted towards storage in the TAG pool [33]. In the present
study, an increased percentage of palmitate in the DAG pool in
the participants with high-IR was observed. Together with the
reduced expression of GPAT1, which is involved in the first
step in TAG synthesis in muscle, this might indicate a reten-
tion of SFA in the NEFA pool and may explain the lower
percentage of PUFA in the DAG pool in the individuals with
high-IR vsmild-IR.More recently, we reported a reduced FSR
of palmitate into intramuscular TAG and DAG in individuals
with combined IGT and IFG compared with participants with
isolated IFG [20]. This has also been shown in obese humans
with impaired glucose metabolism [34]. However, in the pres-
ent study we did not observe significant differences between
the mild-IR and high-IR groups in the FSR of palmitate into
intramuscular TAG and DAG. Nevertheless, these findings
suggest that the postprandial incorporation of FAs in TAG or
DAG is not affected by the degree of IR per se.
Strikingly, in this study the increased saturation in the NEFA
pool was mainly confined to specific SFAs, namely myristic
acid (C14:0), pentadecyclic acid (C15:0) and tricosylic acid
(C23:0). Recently, plasma odd-chain SFAs were shown to be
inversely associated with type 2 diabetes and coronary heart
disease incidence in large epidemiological studies [35].
Interestingly, dairy products are known to be the most impor-
tant source for C15:0 [36]. This would certainly suggest a con-





















































































































































































































































































































































































































































































































































































































































































































































Fig. 4 Intramuscular NEFA (a), DAG (b), TAG (c) and PL (d) composition under fasting conditions. Black bars, mild-IR group; white bars, high-IR
group. *p< 0.05, mild-IR vs high-IR group, Student’s t test for unpaired samples. Values are presented as mean± SEM
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pool, since it has been shown that FA composition of skeletal
muscle reflects dietary FA composition [37]. However, data
related to odd-chain FA metabolism in skeletal muscle are cur-
rently lacking and more research is needed to unravel the role
of odd-chain FAs in intramyocellular lipid turnover and skeletal
muscle IR. Moreover, it is important to note that the increased
content of SFA in the high-IR group might be linked to an
increased ceramide content and higher saturation in the long-
chain fatty acyl-CoA. It has been shown that increased levels of
the SFA palmitate drive ceramide synthesis [38]. However, we
did not measure skeletal muscle ceramide levels or expression
of related genes in the present study. Finally, previous studies
have shown that lower percentages of PUFA in the plasma
membrane are associated with IR [39, 40]. However, in
this study the percentages of total PUFAs in the muscle
PL pool were comparable between groups. It is important
to note that we have not specifically measured muscle
membrane PL content but rather total muscle PL content.
Since most PLs are located mainly in the plasma mem-
brane, the reduced total PL content might reflect a lower
absolute amount of PUFA in the muscle membrane frac-
tion and might therefore contribute to the worsening of
IR in individuals with high-IR.
A limitation of the present study is that we did not perform
a hyperinsulinaemic–euglycaemic clamp test to assess insulin
sensitivity. Rather, we divided groups based on a surrogate
marker of whole-body insulin sensitivity, namely HOMA-
IR. Nevertheless, previous studies have shown strong correla-
tions between HOMA-IR and peripheral insulin sensitivity, as
measured by the gold-standard hyperinsulinaemic–
euglycaemic clamp [41]. Importantly, in this study individuals
in the high-IR group had a significantly lower postprandial net
glucose uptake across forearm muscle as compared with
the individuals with mild-IR, despite having significantly
higher postprandial plasma insulin concentrations. Since
skeletal muscle accounts for approximately 80% of
insulin-mediated glucose uptake in humans [42], these data
clearly indicate a more pronounced skeletal muscle IR in
the individuals with high-IR as compared with those with
mild-IR.
In conclusion, increased skeletal muscle VLDL-TAG ex-
traction in the postprandial state and higher saturation of the
intramuscular NEFA pool are associated with more pro-
nounced IR. These data support an important role for distur-
bances in skeletal muscle FA handling in the progression of
whole-body IR.
Table 4 Fasting skeletal muscle
gene expression Gene Mild-IR High-IR p value
a Total group SE β p valueb
Oxidative metabolism n = 32 n = 30
mCPT1B 1.70± 0.14 1.74± 0.13 0.821 0.006 0.986
PGC1α (PPARGC1A) 0.51 ± 0.05 0.46± 0.04 0.428 0.027 0.847
ACC2 1.52± 0.14 1.59± 0.16 0.741 0.020 0.891
SDHB 2.40± 0.21 1.97± 0.22 0.153 −0.058 0.683
NDUFB5 2.67± 0.17 2.14± 0.23 0.062 −0.243 0.076
Transcription factors n = 28 n = 23
PPARα (PPARA) 1.63 ± 0.16 1.56± 0.11 0.743 0.034 0.808
PPARδ (PPARD) 0.36 ± 0.04 0.48± 0.07 0.114 0.175 0.259
SREBP1c (SREBF1) 0.92 ± 0.10 1.12± 0.14 0.238 0.028 0.840
SREBP2 (SREBF2) 1.43 ± 0.15 1.86± 0.23 0.127 0.266 0.216
ChREBP (CREBBP) 1.02 ± 0.19 0.99± 0.15 0.906 −0.040 0.859
TAG synthesis n = 10 n = 15
GPAT1 (GPAM) 2.55 ± 0.23 1.81± 0.25 0.050 −0.666 0.002
DGAT1 1.89± 0.19 1.77± 0.20 0.667 0.079 0.683
DGAT2 0.31± 0.05 0.25± 0.06 0.509 −0.103 0.671
TAG lipolysis n = 15 n = 8
LPL 0.50± 0.08 0.62± 0.11 0.342 0.018 0.927
ATGL (PNPLA2) 1.11 ± 0.17 2.52± 0.60 0.052 0.522 0.007
HSL (LIPE) 0.44 ± 0.19 0.74± 0.21 0.329 0.130 0.515
Values are presented as mean ± SEM
The italic entries are all gene symbols
a p value for difference between mild-IR and high-IR group, Student’s t test for unpaired samples
b p value for multiple linear regression
mCPT1b, muscle CPT1B; SE β, standardised β coefficient for HOMA-IR, adjusted for sex and BMI
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